Latest News and Press Releases

LONDON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- H118 results were broadly in line with our expectations and Carbios (ALCRB) retains sufficient cash to finance its business until H219. The company...

LONDON, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Quantum Genomics (ALQGC) has announced that the results of its Phase IIb NEW-HOPE study will be presented in a late-breaking presentation at the American...

LONDON, Oct. 05, 2018 (GLOBE NEWSWIRE) -- On 18 June 2018, NeuroVive (NVP:SS) announced that it had out-licensed a subset of compounds from its NVP015 programme (succinate prodrugs) to BridgeBio, a...

LONDON, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Immutep (IMM:ASE) has entered into a clinical trial collaboration and supply agreement with Merck/Pfizer to investigate the combination of its APC...

LONDON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Brighter (BRIG:SS) is a healthtech company developing solutions for chronic diseases. Its initial strategy is the launch of Actiste, a mobile-connected...

LONDON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- TransContainer (TRCN:RM) has continued to show strong results, with Q218 EBITDA, reported on 29 August, increasing by 13% y-o-y. The company is benefiting...

LONDON, Sept. 20, 2018 (GLOBE NEWSWIRE) -- InMed continues to make progress on its biosynthesis platform, optimizing the genes that lead E. coli to express the cannabinoids and scaling up the...

LONDON, Sept. 19, 2018 (GLOBE NEWSWIRE) -- ASLAN announced it would be amending the protocol for its ongoing Chinese pivotal trial of varlitinib in biliary tract cancer. The patients being enrolled...

LONDON, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Kazia Therapeutics has commenced the Phase II program for GDC-0084 in glioblastoma (GDC-0084 was in-licensed from Genentech in 2016). Initial data from the...

LONDON, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech’s (HCM) lead TKI asset, fruquintinib, has received China registration approval from the National Medical Products Administration...